摘要乙型肝炎病毒(Hepatitis B virus,HBV)感染是严重的公共卫生问题,特别是在我国,约有1.2亿人为慢性HBV携带着,给民众健康带来很大危害。对于已感染HBV的人,目前临床上常规的治疗手段效果不能令人满意。然而,随着现代生物技术的发展,为这种疾病的治疗提供了新的思路。本文就目前抗病毒分子生物技术治疗中常用的RNAi技术、反义技术、DNA疫苗技术和投递载体等研究热点进行综述。
5Wu HI,,Huang LR,Huang CC,et al.RNAinterference-media-ted control of hepatitis B virus and emergence of resistant mu-tant[].Gastroenterology.2005
6Jia F,Zhang YZ,Liu CM.Stable inhibition of hepatitis B virus expression and replication in HepG2.2.15 cells by RNA interference based on retrovirus delivery[].Journal of Biotechnology.2007
7[1]Wu JW,Gerber M. The inhibitory effects of antisense RNA on hepatictis B virus surface antigen synthesis J. J Gene Viro, 1997, 78:641-647
8[3]Tseng WC,Huang L. Liposome-based gene therapy J. Res Focus, 1998, 1:206-213
9[4]Gao X, Huang L. A novel cationic liposome reagent for efficient transfection of mammalian Cells J. Biochem Biophys Res Commun,1991,179: 280-285
10[5]Stuart DD, Allen TM. A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stabilityJ.Biochim Biophys Acta, 2000,1463:219-229
